---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-111677"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T21:47:23.062820+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Henry Schein appoints KKR partner Max Lin to board; removes KKR voting commitment

## Summary
- Max Lin, a KKR partner and head of Americas Health Care Private Equity, appointed to board effective May 2, 2025.
- Board size increased to 15 directors; Lin will serve on Nominating/Governance and Strategic Advisory committees.
- Regulatory conditions (HSR, Sweden/Italy approvals) for Lin's appointment satisfied as of April 10, 2025.
- Lin receives standard non-employee director cash compensation (payable to KKR) but no equity grants.
- Letter agreement deletes Section 5.11 of the KKR Strategic Partnership Agreement, removing investor's voting commitment.

## SEC filing metadata
- accession: 0001193125-25-111677
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/0001193125-25-111677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/d71170d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-111677
- JSON: https://secwatch.observer/filing/0001193125-25-111677.json
- Plain text: https://secwatch.observer/filing/0001193125-25-111677.txt

## Key facts
- Executive change
  Max Lin was appointed as Director at HENRY SCHEIN INC.
  - Action: appointed
  - Role: Director
  source text: On May 2, 2025, Max Lin was appointed to the Company’s board of directors (the “ Board ”) as a director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/0001193125-25-111677-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.